(Q39405509)

11 September 2017

Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling (English)

1 reference

11 September 2017

1 reference

Salvia miltiorrhiza

1 reference

Yong Zhang

1

1 reference

11 September 2017

Suk-Hyun Won

2

1 reference

11 September 2017

Cheng Jiang

3

1 reference

11 September 2017

Hyo-Jeong Lee

4

1 reference

11 September 2017

Soo-Jin Jeong

5

1 reference

11 September 2017

Eun-Ok Lee

6

1 reference

11 September 2017

Jinhui Zhang

7

1 reference

11 September 2017

Min Ye

8

1 reference

11 September 2017

Sung-Hoon Kim

9

1 reference

11 September 2017

Junxuan Lü

10

1 reference

11 September 2017

27 January 2012

1 reference

11 September 2017

Pharmaceutical Research

1 reference

11 September 2017

29

1 reference

11 September 2017

6

1 reference

11 September 2017

1595-1608

1 reference

11 September 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Oncogenic activation of androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

The current role of chemotherapy in metastatic hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Androgen receptor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Prolonged treatment with bicalutamide induces androgen receptor overexpression and androgen hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Anticancer effects of tanshinone I in human non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Natural medicine: the genus Angelica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

In vitro cytotoxicity of tanshinones isolated from Salvia miltiorrhiza Bunge against P388 lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Potential anticancer activity of tanshinone IIA against human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Bicalutamide: clinical pharmacokinetics and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

A novel sulindac derivative lacking cyclooxygenase-inhibitory activities suppresses carcinogenesis in the transgenic adenocarcinoma of mouse prostate model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

A novel class of pyranocoumarin anti-androgen receptor signaling compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Galbanic acid isolated from Ferula assafoetida exerts in vivo anti-tumor activity in association with anti-angiogenesis and anti-proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Cryptotanshinone sensitizes DU145 prostate cancer cells to Fas(APO1/CD95)-mediated apoptosis through Bcl-2 and MAPK regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0670-3

Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis

21 January 2018

1 reference

12 December 2020

Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios.

1 reference

12 December 2020

Tanshinone in the treatment of acne (a primary report of 20 cases (author's transl)

1 reference

12 December 2020

Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer

1 reference

12 December 2020

[Sex hormone-like activity of Tanshinone (author's transl)]

1 reference

12 December 2020

A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo.

1 reference

12 December 2020

Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells

1 reference

12 December 2020

Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription

1 reference

12 December 2020

Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells.

1 reference

12 December 2020

Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.

1 reference

12 December 2020

Tanshinone IIA, an ingredient of Salvia miltiorrhiza BUNGE, induces apoptosis in human leukemia cell lines through the activation of caspase-3

1 reference

12 December 2020

The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells.

1 reference

12 December 2020

Bioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice

1 reference

12 December 2020

10.1007/S11095-012-0670-3

Identifiers

DOI

1 reference

11 September 2017

1 reference